在细胞癌中重新编程脂质代谢
Mustafa Khalid Abduljabbar1, Mohammed Merza2,3, Abdulqader Aziz4
1Biotechnology Department, College of Applied Science, Fallujah University, Fallujah, Iraq.
Medical oncology (Northwood, London, England)
|September 6, 2024
概括
高摄入有害脂肪通过破坏脂质代谢和炎症促进癌. 了解这些机制对于制定有针对性的癌预防和治疗策略至关重要.
科学领域:
- 在瘤学瘤学.
- 代谢科学 代谢科学
- 腎臟醫學 腎臟醫學
背景情况:
- 全球肥胖率的上升与癌发病率的增加有关.
- 有害的脂肪消费与包括癌症在内的各种慢性疾病有关.
- 食脂肪和细胞癌之间的特定分子联系需要进一步阐明.
研究的目的:
- 研究连接有害脂肪消费与癌发展的机制.
- 确定关键的分子途径和与这种相关性有关的生物过程.
- 为针对脂质介导脏瘤发生的有针对性的干预提供基础.
主要方法:
- 对当前的研究和临床研究进行了全面的文献综述.
- 分析与脂质代谢和炎症相关的分子通路.
- 检查影响细胞增殖,细胞亡和脏组织中的血管生成的信号级联.
主要成果:
- 脂肪组织因子,炎症和脂质代谢失调创造了一个亲瘤的脏微环境.
- 有害的脂肪会影响癌症进展至关重要的信号通路,包括扩散和血管生成.
- 特定的脂质媒介被确定为癌发生的关键贡献者.
结论:
- 阐明脂质代谢和脏恶性瘤之间的分子联系至关重要.
- 研究结果支持开发针对癌的有针对性的预防和治疗策略.
- 这项研究为公共卫生倡议提供了基础,以减少有害脂肪对脏健康的影响.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K